Ziopharm mgmt and board action spreads enough FUD on it's own. Bio2050 should continue to challenge the investment theme for Ziopharm. If more of us had done that over the last 5 years then we could have all saved ourselves a lot of money. Don't hate the messenger, prove his thesis wrong. That is what makes these boards productive. All the personal attacks back and forth between strong personalities and egos are mind numbing. Counter his arguments with facts, probabilities, and possibilities to make the bull case and leave it at that.